California Biotechnology Foundation is located in Sacramento, CA. The organization was established in 2010. According to its NTEE Classification (U99) the organization is classified as: Science & Technology N.E.C., under the broad grouping of Science & Technology and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. California Biotechnology Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, California Biotechnology Foundation generated $872.6k in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 4.1% each year. All expenses for the organization totaled $899.7k during the year ending 12/2022. While expenses have increased by 5.3% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE PRIMARY OBJECTIVES AND PURPOSES OF THIS CORPORATION SHALL BE TO EDUCATE THE PUBLIC CONCERNING BIOTECHNOLOGY AND HEALTHCARE-RELATED FIE
Describe the Organization's Program Activity:
Part 3 - Line 4a
HIGHLIGHT LIFE SCIENCE INDUSTRYS EFFORTS ON COMBATING COVID-19 AND OTHER ILLNESSES*CBF CONTINUED PUBLISHING WEEKLY COVID-19 UPDATE NEWSLETTER IN 2022 WITH EMERGING NEWS AND PERTINENT INFORMATION RELATED TO LIFE SCIENCE ADVANCEMENTS IN TESTING, TREATMENTS, AND VACCINES.*CBF USED SOCIAL MEDIA, THE WEBSITE, AND DIGITAL ADVERTISING TO SHARE UPDATES ON THE EMERGING MPOX PUBLIC HEALTH CHALLENGE. MATERIALS INCLUDED HIGHLIGHTS OF EFFORTS TO PREVENT MPOX FROM REACHING PANDEMIC STATUS. THESE EFFORTS WERE HIGHLIGHTED IN CBFS MONTHLY NEWSLETTER.*DEVELOPED COVID-19 TIMELINE FACT SHEET ON VACCINES, TESTS, TREATMENTS FOR MONTHLY NEWSLETTER.OTHER EDUCATION *OVERVIEW OF LIFE SCIENCES IN CALIFORNIA TO POLICYMAKERS AT A BRIEFING.*ENGAGED POLICYMAKERS THROUGH REGULAR EMAIL UPDATES, NEWSLETTER CONTENT AND SOCIAL MEDIA. *POSITION CBF AS THE GO-TO INFORMATIONAL RESOURCE TO LEARN MORE ABOUT CA LIFE SCIENCES *EVENT TOUR OF WA LIFE SCIENCES WITH INDUSTRY REPRESENTATIVESCOLLATERAL: FACTS SHEETS, UPDATES, AND NEWSLETTERS*COVID-19 TIMELINE OF LIFE SCIENCE MEDICAL INNOVATIONS FACT SHEET: STEPS TAKEN TO COMBAT THE COVID-19 PANDEMIC AND DISPEL MISINFORMATION RELATED TO VACCINE DEVELOPMENT AND DEPLOYMENT.*LIFE SCIENCE INNOVATIONS FIGHT COVID-19 FACT SHEET: CAS ROLE IN DEVELOPING APPROACHES TO TESTING, CLINICAL TRIALS, VACCINES, AND TREATMENTS.*JAMA STUDY EXAMINES WHETHER 340B DRUG DISCOUNT PROGRAM GENUINELY SERVES VULNERABLE COMMUNITIES FACT SHEET: DEVELOPED IN RESPONSE TO A JAMA STUDY SHOWING THAT 340B BENEFITS PRIMARILY SERVED WHITE, AFFLUENT AREAS.*DMHC REPORT SHOWS HEALTH PLAN PROFIT AND NON-MEDICAL EXPENSES FAR EXCEED RX EXPENDITURES FACT SHEET: DMHC REPORTS ON PRESCRIPTION DRUG CONSUMER EXPENDITURES.MAINTAIN STAKEHOLDER RELATIONSHIPS*BIOCOM 2021 ECONOMIC IMPACT REPORT DATABOOK INFORMATION*REGULARLY ATTENDANCE AT A VARIETY OF STAKEHOLDER MEETINGS*HIGHLIGHT STAKEHOLDERS AT EVENTS, AND IN NEWSLETTERS AND SOCIAL MEDIA *AMPLIFY THE LATEST STAKEHOLDER NEWS AND EVENTS EXECUTE SOCIAL MEDIA CAMPAIGN TO LEVERAGE FACTS AROUND LIFE SCIENCES IN CA*DESIGNED AND EXECUTED MULTIPLE SOCIAL MEDIA AND DIGITAL DISPLAY CAMPAIGNS TO EDUCATE STAKEHOLDERS.*STRATEGICALLY DEPLOYED DIGITAL TO SUPPORT PRIORITY ACTIVITIES OF THE TEAM TO BRING HISTORICALLY OFFLINE ACTIVITIES INTO A DIGITAL ENVIRONMENT. *CBF MAINTAINS A ROBUST ORGANIC SOCIAL MEDIA PRESENCE INCLUDING SHARING THE LATEST NEWS AND EVENTS FROM STAKEHOLDER AND HIGHLIGHTING HEALTHCARE STAKEHOLDERS ON SOCIAL MEDIA DURING AWARENESS MONTHS SUCH AS HISPANIC HERITAGE MONTH AND BREAST CANCER AWARENESS MONTH.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Patricia Cooper Treasurer | OfficerTrustee | 40 | $169,180 |
Joseph Panetta Chairman | OfficerTrustee | 1 | $0 |
Amanda Banks Secretary | OfficerTrustee | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Lucas Public Affairs Consulting | 12/30/22 | $149,760 |
Unearth Consulting | 12/30/22 | $227,000 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $415,000 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $457,550 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $872,550 |
Total Program Service Revenue | $0 |
Investment income | $0 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $872,550 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $207,162 |
Compensation of current officers, directors, key employees. | $41,432 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $1,838 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $415,260 |
Advertising and promotion | $0 |
Office expenses | $10,532 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $8,022 |
Travel | $18,768 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $183,634 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $1,250 |
All other expenses | $0 |
Total functional expenses | $899,739 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $40,661 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $40,661 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $40,661 |
Total liabilities and net assets/fund balances | $40,661 |